DiNubile M J
Department of Medicine, Cooper Hospital/University Medical Center, Camden, New Jersey.
Ann Intern Med. 1988 Feb;108(2):289-92. doi: 10.7326/0003-4819-108-2-289.
Infection is the major cause of death in neutropenic patients. Because of the lack of acute inflammatory cells, the usual signs of infection are often absent in these patients. Therefore, unexplained fever in a neutropenic patient requires prompt initiation of antibiotic therapy. Many physicians advocate continuing antibiotic therapy until neutropenia resolves. However, prolonged treatment with broad-spectrum antibiotics increases the risks of drug toxicity and superinfection with resistant bacteria and fungi. Based on a critical review of the literature and a large personal clinical experience, I offer tentative guidelines for withdrawing antibiotic therapy in persistently neutropenic patients. When antibiotic therapy is discontinued, frequent and careful monitoring of these patients and a low threshold for reinstituting antibiotic therapy are essential.
感染是中性粒细胞减少患者死亡的主要原因。由于缺乏急性炎症细胞,这些患者通常没有感染的常见体征。因此,中性粒细胞减少患者出现不明原因发热需要立即开始抗生素治疗。许多医生主张持续使用抗生素治疗,直到中性粒细胞减少症缓解。然而,长期使用广谱抗生素会增加药物毒性以及耐药细菌和真菌感染的风险。基于对文献的批判性回顾和丰富的个人临床经验,我为持续中性粒细胞减少患者停用抗生素治疗提供初步指导原则。当停用抗生素治疗时,对这些患者进行频繁且仔细的监测以及重新使用抗生素治疗的低阈值至关重要。